These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23274815)

  • 1. Use of portable X-ray fluorescence (PXRF) in vivo as an alternative technique for the assessment of iron levels in patients with thalassemia and hemochromatosis.
    Estevam M; Appoloni CR
    Health Phys; 2013 Feb; 104(2):132-8. PubMed ID: 23274815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive analysis of skin iron and zinc levels in beta-thalassemia major and intermedia.
    Gorodetsky R; Goldfarb A; Dagan I; Rachmilewitz EA
    J Lab Clin Med; 1985 Jan; 105(1):44-51. PubMed ID: 3968464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the accuracy of a portable
    Bangash SU; McNeill FE; Farquharson MJ
    Biomed Phys Eng Express; 2024 Apr; 10(3):. PubMed ID: 38604150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The feasibility of a sensitive low-dose method for the in vivo evaluation of Fe in skin using K-shell x-ray fluorescence (XRF).
    Farquharson MJ; Bradley DA
    Phys Med Biol; 1999 Apr; 44(4):955-65. PubMed ID: 10232808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver.
    Mazza P; Giua R; De Marco S; Bonetti MG; Amurri B; Masi C; Lazzari G; Rizzo C; Cervellera M; Peluso A
    Haematologica; 1995; 80(5):398-404. PubMed ID: 8566878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron chelation therapy in hereditary hemochromatosis and thalassemia intermedia: regulatory and non regulatory mechanisms of increased iron absorption.
    Kontoghiorghes GJ; Spyrou A; Kolnagou A
    Hemoglobin; 2010 Jun; 34(3):251-64. PubMed ID: 20524815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A noninvasive method for the evaluation of tissue iron deposition in beta-thalassemia major.
    Zeimer R; Belkin M; Leitersdorff E; Rachmilewitz EA
    J Lab Clin Med; 1978 Jan; 91(1):24-31. PubMed ID: 618988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging (MRI) findings of joints in young beta-thalassemia major patients: fluid surrounding the scaphoid bone: a novel finding, as the possible effect of secondary hemochromatosis.
    Karimi M; Jamalian N; Rasekhi A; Kashef S
    J Pediatr Hematol Oncol; 2007 Jun; 29(6):393-8. PubMed ID: 17551401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can iron chelators influence the progression of atherosclerosis?
    Marx JJ; Kartikasari AE; Georgiou NA
    Hemoglobin; 2008; 32(1-2):123-34. PubMed ID: 18274990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin iron concentration: a simple, highly sensitive method for iron stores evaluation in thalassemia patients.
    Youssry I; Mohsen NA; Shaker OG; El-Hennawy A; Fawzy R; Abu-Zeid NM; El-Beshlawy A
    Hemoglobin; 2007; 31(3):357-65. PubMed ID: 17654073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy.
    McLaren GD; Muir WA; Kellermeyer RW
    Crit Rev Clin Lab Sci; 1983; 19(3):205-66. PubMed ID: 6373141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thalassemia minor with iron overload: genetic and clinical study of a family].
    Queipo de Llano MP; Yebra M; Moreno M; Lacoma F; Gea JC; Berrocal E
    Med Clin (Barc); 1991 Nov; 97(17):660-2. PubMed ID: 1762461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H63D mutation in the HFE gene increases iron overload in beta-thalassemia carriers.
    Melis MA; Cau M; Deidda F; Barella S; Cao A; Galanello R
    Haematologica; 2002 Mar; 87(3):242-5. PubMed ID: 11869934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear resonance scattering measurement of human iron stores.
    Wielopolski L; Ancona RC; Mossey RT; Vaswani AN; Cohn SH
    Med Phys; 1985; 12(4):401-4. PubMed ID: 4033584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive in-vivo measurement of hepatic and cardiac iron.
    Wielopolski L; Zaino EC
    J Nucl Med; 1992 Jul; 33(7):1278-82. PubMed ID: 1613565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nuclear magnetic resonance and iron overload in thalassemia].
    Schettini F; De Mattia D; Cavallo L; Sabato V; Santoro N; Del Vecchio GC; Martinelli G; Martinelli A; Di Bartolomeo P; Di Girolamo G
    Minerva Pediatr; 1991 Dec; 43(12):777-81. PubMed ID: 1798402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of iron overload on the immune system.
    Walker EM; Walker SM
    Ann Clin Lab Sci; 2000 Oct; 30(4):354-65. PubMed ID: 11045759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant primary hemochromatosis and beta-thalassemia trait: iron depletion by erythrocytapheresis and desferrioxamine.
    Cesana M; Mandelli C; Tiribelli C; Bianchi PA; Conte D
    Am J Gastroenterol; 1989 Feb; 84(2):150-2. PubMed ID: 2916524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Disease caused by iron overload associated to minor beta thalassemia].
    García Pont J; Moreu Araño I; Asensio Montoro A; Rueda García A
    An Med Interna; 1993 Apr; 10(4):203. PubMed ID: 8513091
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-transferrin bound iron in Thalassemia: differential detection of redox active forms in children and older patients.
    Breuer W; Ghoti H; Shattat A; Goldfarb A; Koren A; Levin C; Rachmilewitz E; Cabantchik ZI
    Am J Hematol; 2012 Jan; 87(1):55-61. PubMed ID: 22125177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.